[go: up one dir, main page]

FI953081A0 - Sekviterpeenit, niiden valmistaminen ja niiden käyttö inhibiittoreina, jotka vaikuttavat GABA-bentsodiatsepiinireseptoriin - Google Patents

Sekviterpeenit, niiden valmistaminen ja niiden käyttö inhibiittoreina, jotka vaikuttavat GABA-bentsodiatsepiinireseptoriin

Info

Publication number
FI953081A0
FI953081A0 FI953081A FI953081A FI953081A0 FI 953081 A0 FI953081 A0 FI 953081A0 FI 953081 A FI953081 A FI 953081A FI 953081 A FI953081 A FI 953081A FI 953081 A0 FI953081 A0 FI 953081A0
Authority
FI
Finland
Prior art keywords
sequiterpenes
benzodiazepines
gaba
preparation
inhibitors acting
Prior art date
Application number
FI953081A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI953081A (fi
Inventor
Didier Vincent Renno
Gerard Bernard O'beirne
Brent Raymond Copp
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of FI953081A publication Critical patent/FI953081A/fi
Publication of FI953081A0 publication Critical patent/FI953081A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI953081A 1992-12-22 1995-06-21 Sekviterpeenit, niiden valmistaminen ja niiden käyttö inhibiittoreina, jotka vaikuttavat GABA-bentsodiatsepiinireseptoriin FI953081A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226724A GB9226724D0 (en) 1992-12-22 1992-12-22 Pharmaceutical compounds
PCT/GB1993/002632 WO1994014814A1 (en) 1992-12-22 1993-12-22 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor

Publications (2)

Publication Number Publication Date
FI953081A FI953081A (fi) 1995-06-21
FI953081A0 true FI953081A0 (fi) 1995-06-21

Family

ID=10727034

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953081A FI953081A0 (fi) 1992-12-22 1995-06-21 Sekviterpeenit, niiden valmistaminen ja niiden käyttö inhibiittoreina, jotka vaikuttavat GABA-bentsodiatsepiinireseptoriin

Country Status (23)

Country Link
US (1) US5565486A (xx)
EP (1) EP0675888A1 (xx)
JP (1) JPH08504804A (xx)
KR (1) KR950704324A (xx)
AU (1) AU677272B2 (xx)
BG (1) BG99736A (xx)
BR (1) BR9307712A (xx)
CA (1) CA2151251A1 (xx)
CZ (1) CZ284121B6 (xx)
FI (1) FI953081A0 (xx)
GB (2) GB9226724D0 (xx)
HU (1) HUT71859A (xx)
IL (1) IL108140A (xx)
MX (1) MX9400174A (xx)
NO (1) NO952483L (xx)
NZ (1) NZ258986A (xx)
PL (1) PL309628A1 (xx)
RU (1) RU95113350A (xx)
SG (1) SG67345A1 (xx)
SK (1) SK77595A3 (xx)
TW (1) TW242141B (xx)
WO (1) WO1994014814A1 (xx)
ZA (1) ZA939626B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070161095A1 (en) * 2005-01-18 2007-07-12 Gurin Michael H Biomass Fuel Synthesis Methods for Increased Energy Efficiency
US9782454B2 (en) 2010-04-22 2017-10-10 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
US9789164B2 (en) 2013-03-15 2017-10-17 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348284A (ja) * 1986-08-18 1988-02-29 Yamanouchi Pharmaceut Co Ltd 新抗生物質ｙｐ−０２９０８ｌ−ａおよびその製造法
DE3850260T2 (de) * 1987-02-06 1994-09-22 Snow Brand Milk Prod Co Ltd Herstellung von 7-beta-Hydroxy-4-pregnen-3,20-dion-Derivaten.
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
JP2842613B2 (ja) * 1989-04-28 1999-01-06 塩野義製薬株式会社 フォスフォリパーゼａ▲下２▼阻害物質
JPH03108490A (ja) * 1989-06-30 1991-05-08 Shionogi & Co Ltd フォスフォリパーゼａ↓２阻害物質
US5130430A (en) * 1990-10-31 1992-07-14 Neurogen Corporation 2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
US5189050A (en) * 1991-06-03 1993-02-23 Merck & Co., Inc. Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder

Also Published As

Publication number Publication date
GB2284603B (en) 1996-03-27
BR9307712A (pt) 1999-08-31
JPH08504804A (ja) 1996-05-28
NZ258986A (en) 1996-11-26
ZA939626B (en) 1994-08-18
FI953081A (fi) 1995-06-21
IL108140A0 (en) 1994-04-12
TW242141B (xx) 1995-03-01
GB9503413D0 (en) 1995-04-12
CA2151251A1 (en) 1994-07-07
AU5709694A (en) 1994-07-19
SG67345A1 (en) 1999-09-21
AU677272B2 (en) 1997-04-17
GB2284603A (en) 1995-06-14
PL309628A1 (en) 1995-10-30
US5565486A (en) 1996-10-15
SK77595A3 (en) 1995-12-06
MX9400174A (es) 1994-07-29
RU95113350A (ru) 1997-06-10
KR950704324A (ko) 1995-11-17
NO952483D0 (no) 1995-06-21
GB9226724D0 (en) 1993-02-17
BG99736A (bg) 1996-04-30
HU9501840D0 (en) 1995-08-28
NO952483L (no) 1995-08-15
EP0675888A1 (en) 1995-10-11
IL108140A (en) 1997-06-10
CZ164695A3 (en) 1995-11-15
WO1994014814A1 (en) 1994-07-07
CZ284121B6 (cs) 1998-08-12
HUT71859A (en) 1996-02-28

Similar Documents

Publication Publication Date Title
FI932961L (fi) Metallocener med arylsubsituerade indenylderivat som ligander, foerfarande foer framstaellning av dessa och anvaendning av dessa som katalysatorer
FI932659L (fi) Gallsyraderivat, foerfaranden foer deras framstaellning och anvaendning avdessa foereningar som laekemedel
FI934220A0 (fi) Piperidinderivat, framstaellning daerav och anvaendning daerav vid en terapi
FI934109L (fi) Bensoylguanidiner, foerfarande foer framstaellning av dessa, deras anvaendning som laekemedel och laekemedel innehaollande dessa
FI925926L (fi) Sammansaettning som innehaoller hydrerade sackarider med laog kariesframkallande effekt, foerfarande foer framstaellning av dessa och tillaempningen av denna sammansaettning
TR199501560A2 (tr) Kademeli olarak saliverilen kafein formülasyonu.
FI931250L (fi) Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI945662A0 (fi) Roerformad stomme, i synnerhet som hylselement och med hylselement foersedd stomme
FI931707L (fi) 1,2,4-oxadiazolyl-fenoxialkylisoxazoler och deras anvaendning som virusmotarbetande aemnen
FI931336L (fi) Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk
FI955165A (fi) 4-aryyli-4-hydroksi-tetrahydropyraanit ja 3-aryyli-3-hydroksi-tetrahydrofuraanit 5-lipoksygenaasi inhibiittoreina
FI940992A0 (fi) Cylindergrupp med enkelt viradrag i torkningspartiet av en pappersmaskin och torkningsparti i pappersmaskin som innehaoller dessa
FI933376A0 (fi) 4-amino-3-acylkinolinderivater och deras anvaendning som inhibitorer avmagsyrasekretion
TR199501553A2 (tr) Sefem bilesimleri ve bunlarin farmasötik olarak kullanilmasi.
FI953081A0 (fi) Sekviterpeenit, niiden valmistaminen ja niiden käyttö inhibiittoreina, jotka vaikuttavat GABA-bentsodiatsepiinireseptoriin
FI955335A0 (fi) Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav foer anvaendning som kontrastmedel och foerfarande foer framstaellning av dessa
FI935509L (fi) Sampolymerer baserade pao cykliska estrar och deras anvaendning som kirurgiska implantat
FI931159L (fi) Dosaerosoler, som innehaoller som aktivt aemne flezelastin och med dettarelaterade strukturer
FI934468L (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytes mellanprodukter
BR9607419A (pt) Formulação para bebidas instanâneas
ES1022839Y (es) Bragas monouso.
ITMI941135A0 (it) Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono
FR2757360B1 (fr) Dispositif modulaire d'agencement, notamment du type gondole
FI940493A0 (fi) Anordning som hindrar igenfrysning av ventilationsroeret i en avloppsledning och ocksao vattenlaeckage pao genomfoeringsstaellen
FI933945A0 (fi) Foerfarande foer maetning av formfel pao banmaterialrullar, i synnerhet pappersrullar och anordning avsedd foer genomfoerande av foerfarandet

Legal Events

Date Code Title Description
FD Application lapsed